StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.21+0.01 (+6.06%)

Close on Nov 17, 2026Market cap $947.51KP/E –Yield –

Oragenics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Oragenics's operating income for the twelve months ending Jun 30, 2026 was -$10.47M. For fiscal 2025 it was -$9.36M. The highest annual figure on record is -$5.82M in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.36M–
FY2024Dec 31, 2024-$10.56M–
FY2023Dec 31, 2023-$20.90M–
FY2022Dec 31, 2022-$14.42M–
FY2021Dec 31, 2021-$15.77M–
FY2020Dec 31, 2020-$26.64M–
FY2019Dec 31, 2019-$15.88M–
FY2018Dec 31, 2018-$9.99M–
FY2017Dec 31, 2017-$6.72M–
FY2016Dec 31, 2016-$8.54M–
FY2015Dec 31, 2015-$11.78M–
FY2014Dec 31, 2014-$5.82M–
FY2013Dec 31, 2013-$16.21M–
FY2012Dec 31, 2012-$12.43M–
FY2011Dec 31, 2011-$7.35M–
FY2010Dec 31, 2010-$7.90M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.59M–
Q1 FY2026Mar 31, 2026-$2.26M–
Q4 FY2025Dec 31, 2025-$2.50M–
Q3 FY2025Sep 30, 2025-$3.12M–
Q2 FY2025Jun 30, 2025-$1.71M–
Q1 FY2025Mar 31, 2025-$2.03M–
Q4 FY2024Dec 31, 2024-$3.36M–
Q3 FY2024Sep 30, 2024-$2.44M–
Q2 FY2024Jun 30, 2024-$2.31M–
Q1 FY2024Mar 31, 2024-$2.46M–
Q4 FY2023Dec 31, 2023-$12.80M–
Q3 FY2023Sep 30, 2023-$2.09M–
Q2 FY2023Jun 30, 2023-$3.11M–
Q1 FY2023Mar 31, 2023-$2.90M–
Q4 FY2022Dec 31, 2022-$2.30M–
Q3 FY2022Sep 30, 2022-$3.91M–
Q2 FY2022Jun 30, 2022-$3.60M–
Q1 FY2022Mar 31, 2022-$4.61M–
Q4 FY2021Dec 31, 2021-$2.30M–
Q3 FY2021Sep 30, 2021-$4.39M–
Q2 FY2021Jun 30, 2021-$3.84M–
Q1 FY2021Mar 31, 2021-$5.24M–
Q4 FY2020Dec 31, 2020-$4.55M–
Q3 FY2020Sep 30, 2020-$4.51M–
Q2 FY2020Jun 30, 2020-$12.35M–
Q1 FY2020Mar 31, 2020-$5.23M–
Q4 FY2019Dec 31, 2019-$3.66M–
Q3 FY2019Sep 30, 2019-$3.92M–
Q2 FY2019Jun 30, 2019-$4.90M–
Q1 FY2019Mar 31, 2019-$3.39M–
Q4 FY2018Dec 31, 2018-$2.82M–
Q3 FY2018Sep 30, 2018-$2.76M–
Q2 FY2018Jun 30, 2018-$2.28M–
Q1 FY2018Mar 31, 2018-$2.12M–
Q4 FY2017Dec 31, 2017-$1.41M–
Q3 FY2017Sep 30, 2017-$1.92M–
Q2 FY2017Jun 30, 2017-$1.40M–
Q1 FY2017Mar 31, 2017-$1.99M–
Q4 FY2016Dec 31, 2016-$2.71M–
Q3 FY2016Sep 30, 2016-$2.03M–

More Oragenics figures

See a number that looks wrong?